Ariadna Giro

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Scaffold-free three-dimensional culture of chronic lymphocytic leukaemia preserves B-T-cell cross-talk and enables drug response profiling.

Scaffold-free three-dimensional culture of chronic lymphocytic leukaemia preserves B-T-cell cross-talk and enables drug response profiling.

Journal: British journal of haematology
Published: March 20, 2026

CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

Journal: Blood
Published: December 05, 2025

Implementation of ambulatory health care quality standards in an Occupational Mutual Insurance Company.

Implementation of ambulatory health care quality standards in an Occupational Mutual Insurance Company.

Journal: Journal of healthcare quality research
Published: July 10, 2025

Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.

Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.

Journal: Leukemia
Published: June 13, 2023

SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia.

SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia.

Journal: Life science alliance
Published: January 27, 2023

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Journal: Nature medicine
Published: November 10, 2021

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia.

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia.

Journal: Scientific reports
Published: August 02, 2020

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 22, 2019

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.

Journal: Oncogene
Published: September 18, 2018

Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.

Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.

Journal: International journal of cancer
Published: May 09, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026